Invitation to Neurotrauma Community to Submit Proposals for Candidate Drugs for TRACK-TBI NET Phase 2 Trials

December 20, 2018

TRACK-TBI NET is seeking proposals for candidate pharmacologic agents for Phase 2 TBI clinical trials. Interested parties should submit a Clinical Trial Synopsis by or before January 28, 2019.

Submission Details

TRACK-TBI NETWORK

Invitation to Neurotrauma Community to Submit Proposals for Candidate Drugs for TRACK-TBI NET Phase 2 Trials

News

FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion

Position Opening - Sr. Clinical Research Coordinator

Abbott receives FDA clearance for commercially available TBI blood test

TRACK-TBI NET selected as research network for BARDA-sponsored trial of Abbott TBI Aid-In-Diagnosis Trial

TRACK-TBI NETWORK

Search form

You are here

Invitation to Neurotrauma Community to Submit Proposals for Candidate Drugs for TRACK-TBI NET Phase 2 Trials

News

FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion

Position Opening - Sr. Clinical Research Coordinator

Abbott receives FDA clearance for commercially available TBI blood test

TRACK-TBI NET selected as research network for BARDA-sponsored trial of Abbott TBI Aid-In-Diagnosis Trial